Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
TECHNESCAN HIDA is a radiopharmaceutical diagnostic agent containing technetium Tc-99m lidofenin, used for hepatobiliary imaging to assess liver function and biliary tract patency. It is injected intravenously and localizes in the liver and biliary system, enabling clinicians to visualize organ function and diagnose conditions such as acute cholecystitis, biliary dyskinesia, and hepatic dysfunction. This agent belongs to the nuclear medicine/diagnostic imaging category and does not treat disease but provides functional diagnostic information.
As LOE approaches, commercial teams are likely consolidating; opportunities focus on defending market share against generic radiopharmaceutical alternatives and optimizing manufacturing efficiency.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on TECHNESCAN HIDA offers limited growth trajectory given LOE approaching status; roles emphasize operational efficiency, regulatory maintenance, and legacy product stewardship rather than market expansion. Career value lies in diagnostic/radiopharmaceutical expertise and cost optimization experience.
Worked on TECHNESCAN HIDA at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.